Cost analysis favorably compares proton APBI with radiation WBI
Approved for patients who received one androgen receptor pathway inhibitor (ARPI) but not chemotherapy
First European installation to be in Netherlands
Market analysis from the experts at symplr
Research funded by feds to save lives offers faster, cheaper testing
Q&A with ASTRO president Dr. Laura Dawson
New paper offers tips for balancing benefits and risks without stirring up radiophobia
Will add BNCT as a radiotherapy modality through alliance with Neutron Therapeutics
$190 million and 12 years in the making
The biggest MR stories of the year from our Daily News online
Demand grew alongside limited expansion in installed imaging capacity, according to IMV
The first proton therapy center in the Hainan province
Staff will bring together 70 years' net worth of proton experience
Insights from the 6th International Symposium on Focused Ultrasound
Will integrate quantitation with image analysis for different medical disciplines
Seeking to eventually adjust the direction of ion beams in real time
Patients reluctantly in the dark when it comes to understanding imaging
ASTRO applauds
Measuring appropriate use and untapped potential with two new studies
A comparison of conventional radiation therapy and next-generation radiosurgery.
Could lead to genetic screenings to identify humans who should not be imaged with radiation
Replacement for heavy lead aprons
Scott Warwick was chosen for the role following a nationwide search
Noninvasively ablates cancerous liver tissue
